サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/06/30 | 1,720 | 1,761 | 1,695 | 1,720 | +3 | +0.2% | 450,800 |
| 2016/06/29 | 1,748 | 1,760 | 1,711 | 1,717 | -3 | -0.2% | 464,200 |
| 2016/06/28 | 1,696 | 1,750 | 1,675 | 1,720 | -1 | -0.1% | 414,100 |
| 2016/06/27 | 1,640 | 1,778 | 1,614 | 1,721 | +101 | +6.2% | 793,700 |
| 2016/06/24 | 1,830 | 1,835 | 1,450 | 1,620 | -140 | -8% | 1,152,300 |
| 2016/06/23 | 1,710 | 1,797 | 1,677 | 1,760 | +11 | +0.6% | 513,200 |
| 2016/06/22 | 1,703 | 1,841 | 1,650 | 1,749 | +32 | +1.9% | 987,100 |
| 2016/06/21 | 1,712 | 1,766 | 1,690 | 1,717 | +5 | +0.3% | 432,300 |
| 2016/06/20 | 1,634 | 1,734 | 1,634 | 1,712 | +62 | +3.8% | 484,400 |
| 2016/06/17 | 1,739 | 1,768 | 1,620 | 1,650 | -20 | -1.2% | 667,000 |
| 2016/06/16 | 1,900 | 1,900 | 1,660 | 1,670 | -234 | -12.3% | 1,281,500 |
| 2016/06/15 | 1,769 | 1,964 | 1,768 | 1,904 | +136 | +7.7% | 1,354,900 |
| 2016/06/14 | 1,999 | 1,999 | 1,656 | 1,768 | -240 | -12% | 2,043,400 |
| 2016/06/13 | 1,979 | 2,057 | 1,940 | 2,008 | -55 | -2.7% | 1,226,200 |
| 2016/06/10 | 2,100 | 2,119 | 2,000 | 2,063 | ±0 | ±0% | 2,600,800 |
| 2016/06/09 | 1,851 | 2,088 | 1,850 | 2,063 | +281 | +15.8% | 5,910,100 |
| 2016/06/08 | 1,814 | 1,825 | 1,746 | 1,782 | -19 | -1.1% | 517,100 |
| 2016/06/07 | 1,830 | 1,833 | 1,782 | 1,801 | -24 | -1.3% | 514,600 |
| 2016/06/06 | 1,825 | 1,830 | 1,768 | 1,825 | +28 | +1.6% | 723,700 |
| 2016/06/03 | 1,739 | 1,808 | 1,714 | 1,797 | +138 | +8.3% | 1,395,400 |
| 2016/06/02 | 1,689 | 1,740 | 1,616 | 1,659 | -30 | -1.8% | 353,000 |
| 2016/06/01 | 1,720 | 1,720 | 1,676 | 1,689 | -39 | -2.3% | 336,100 |
| 2016/05/31 | 1,670 | 1,728 | 1,655 | 1,728 | +56 | +3.3% | 718,400 |
| 2016/05/30 | 1,600 | 1,677 | 1,560 | 1,672 | +40 | +2.5% | 427,200 |
| 2016/05/27 | 1,606 | 1,643 | 1,606 | 1,632 | -14 | -0.9% | 265,700 |
| 2016/05/26 | 1,568 | 1,679 | 1,551 | 1,646 | -82 | -4.7% | 1,046,300 |
| 2016/05/25 | 1,800 | 1,835 | 1,673 | 1,728 | -63 | -3.5% | 1,001,700 |
| 2016/05/24 | 1,722 | 1,907 | 1,710 | 1,791 | +80 | +4.7% | 1,508,800 |
| 2016/05/23 | 1,700 | 1,740 | 1,670 | 1,711 | +84 | +5.2% | 818,400 |
| 2016/05/20 | 1,556 | 1,635 | 1,546 | 1,627 | +74 | +4.8% | 433,100 |
| 2016/05/19 | 1,626 | 1,650 | 1,527 | 1,553 | -33 | -2.1% | 699,400 |
| 2016/05/18 | 1,600 | 1,697 | 1,562 | 1,586 | +66 | +4.3% | 1,201,000 |
| 2016/05/17 | 1,561 | 1,589 | 1,502 | 1,520 | +29 | +1.9% | 529,800 |
| 2016/05/16 | 1,520 | 1,602 | 1,451 | 1,491 | -18 | -1.2% | 471,800 |
| 2016/05/13 | 1,479 | 1,523 | 1,406 | 1,509 | -7 | -0.5% | 538,400 |
| 2016/05/12 | 1,592 | 1,592 | 1,513 | 1,516 | -54 | -3.4% | 439,800 |
| 2016/05/11 | 1,566 | 1,608 | 1,551 | 1,570 | ±0 | ±0% | 337,600 |
| 2016/05/10 | 1,583 | 1,593 | 1,544 | 1,570 | -21 | -1.3% | 318,600 |
| 2016/05/09 | 1,595 | 1,620 | 1,583 | 1,591 | +11 | +0.7% | 356,900 |
| 2016/05/06 | 1,610 | 1,629 | 1,559 | 1,580 | -18 | -1.1% | 429,500 |
| 2016/05/02 | 1,608 | 1,693 | 1,588 | 1,598 | +30 | +1.9% | 766,200 |
| 2016/04/28 | 1,615 | 1,625 | 1,504 | 1,568 | -48 | -3% | 461,400 |
| 2016/04/27 | 1,644 | 1,673 | 1,558 | 1,616 | +30 | +1.9% | 523,500 |
| 2016/04/26 | 1,742 | 1,765 | 1,540 | 1,586 | -203 | -11.3% | 1,216,700 |
| 2016/04/25 | 1,742 | 1,868 | 1,737 | 1,789 | -33 | -1.8% | 671,700 |
| 2016/04/22 | 1,890 | 1,897 | 1,760 | 1,822 | -105 | -5.4% | 823,500 |
| 2016/04/21 | 1,969 | 1,969 | 1,857 | 1,927 | +2 | +0.1% | 771,800 |
| 2016/04/20 | 2,008 | 2,028 | 1,809 | 1,925 | -61 | -3.1% | 1,031,500 |
| 2016/04/19 | 2,000 | 2,030 | 1,965 | 1,986 | +21 | +1.1% | 1,056,600 |
| 2016/04/18 | 1,915 | 2,010 | 1,900 | 1,965 | +60 | +3.1% | 1,431,200 |
2151～
2200
件表示中 / 2451件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 239,900円 | - | - | 0.00% | - | 111.12倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 409,100円 | +30.5% | +111.0% | 4.64% | 11.53倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,000円 | +14.5% | -2.3% | 2.43% | 13.57倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 254,800円 | +15.0% | -7.3% | 2.75% | 8.36倍 | 0.79倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 450,000円 | +7.1% | -35.0% | 2.67% | 37.21倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
